Clinical Study
Immunoreactivity of the 14F7 Mab (Raised against N-Glycolyl GM3 Ganglioside) as a Positive Prognostic Factor in Non-Small-Cell Lung Cancer
Table 6
Relation between S-phase fraction and mitotic index with the 14F7 Mab immunoreactivity in diploid non-small-cell lung carcinoma.
| Proliferation rates | 14F7 Mab reactivity | | Negative | Weak | Moderate | Intense | Spearman correlation | No. (%) | No. (%) | No. (%) | No. (%) | value | |
| S-phase fraction (SPF) | | | | | 0.0208 | 0.5126 | 0–5 | — | — | — | — | | | 6–25 | — | 3 (27.3) | — | — | | | 26–50 | — | — | 6 (54.5) | — | | | >50 | — | — | — | 2 (18.2) | | | Total | 0 | 3 (27.3) | 6 (54.5) | 2 (18.2) | | | Mitotic index | | | | | 0.0284 | −0.4143 | No evident | — | — | — | 2 (7.1) | | | Low | 1 (3.6) | — | 2 (7.1) | 6 (21.4) | | | Moderate | 1 (3.6) | 2 (7.1) | 7 (25.0) | 3 (10.7) | | | High | — | 1 (3.6) | 2 (7.1) | 1 (3.6) | | | Total | 2 (7.1) | 3 (10.7) | 11 (39.3) | 12 (42.8) | | |
|
|
No. Number of cases, % percentages, value using Spearman correlation test, s Spearman correlation coefficient.
|